These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31870855)

  • 1. Blockade of the dopaminergic neurotransmission with AMPT and reserpine induces a differential expression of genes of the dopaminergic phenotype in substantia nigra.
    Ortiz-Padilla S; Soto-Orduño E; Barrios ME; Manjarrez AA; Bastián Y; Mendez JA
    Neuropharmacology; 2020 Apr; 166():107920. PubMed ID: 31870855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of dopamine receptors in regulating the size of axonal arbors.
    Parish CL; Finkelstein DI; Drago J; Borrelli E; Horne MK
    J Neurosci; 2001 Jul; 21(14):5147-57. PubMed ID: 11438590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.
    Biggs CS; Fowler LJ; Whitton PS; Starr MS
    Eur J Pharmacol; 1996 Mar; 299(1-3):83-91. PubMed ID: 8901010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of acetylcholinesterase in vivo is regulated by dopaminergic systems in the guinea-pig substantia nigra.
    Dally JJ; Greenfield SA
    Neurochem Int; 1994 Oct; 25(4):339-44. PubMed ID: 7820067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiography.
    Trugman JM; James CL
    J Neurosci; 1992 Jul; 12(7):2875-9. PubMed ID: 1613560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D1 and D2 receptors and to axotomy.
    Nissbrandt H; Hjorth S
    J Neural Transm Gen Sect; 1992; 90(1):13-26. PubMed ID: 1361343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of dopaminergic inputs elongates the primary cilia of striatal neurons.
    Miyoshi K; Kasahara K; Murakami S; Takeshima M; Kumamoto N; Sato A; Miyazaki I; Matsuzaki S; Sasaoka T; Katayama T; Asanuma M
    PLoS One; 2014; 9(5):e97918. PubMed ID: 24830745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ventral tegmental area dopamine neurons produces wakefulness through dopamine D
    Oishi Y; Suzuki Y; Takahashi K; Yonezawa T; Kanda T; Takata Y; Cherasse Y; Lazarus M
    Brain Struct Funct; 2017 Aug; 222(6):2907-2915. PubMed ID: 28124114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular anatomy of the development of the human substantia nigra.
    Aubert I; Brana C; Pellevoisin C; Giros B; Caille I; Carles D; Vital C; Bloch B
    J Comp Neurol; 1997 Mar; 379(1):72-87. PubMed ID: 9057113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra.
    Biggs CS; Starr MS
    Neurosci Biobehav Rev; 1997 Jul; 21(4):497-504. PubMed ID: 9195608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.
    Qin ZH; Weiss B
    Eur J Pharmacol; 1994 Sep; 269(1):25-33. PubMed ID: 7828655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.
    Wacan JJ; Reichel CM; Farley CM; McDougall SA
    Psychopharmacology (Berl); 2006 Mar; 185(1):104-11. PubMed ID: 16447063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
    Florán B; Barajas C; Florán L; Erlij D; Aceves J
    Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Midbrain Dopamine Neuron Activity in Negative Reinforcement Learning in Mice.
    Diao Z; Yao L; Cheng Q; Wu M; Di Y; Qian Z; Wei C; Liu Y; Tian Y; Ren W
    Mol Neurobiol; 2021 Nov; 58(11):5667-5681. PubMed ID: 34387814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
    Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
    J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.